SK Bioscience Co Ltd (302440) — Working Capital to Net Assets Ratio
SK Bioscience Co Ltd (302440) has a Working Capital to Net Assets ratio of 50.7% as of September 2025. Working capital of ₩1.05 Trillion (current assets of ₩1.37 Trillion minus current liabilities of ₩321.99 Billion) is measured against net assets of ₩2.07 Trillion. A higher ratio indicates strong short-term liquidity financed by the equity base. See net asset quality index of SK Bioscience Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
SK Bioscience Co Ltd Working Capital to Net Assets (2018–2024)
This chart shows how SK Bioscience Co Ltd's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of September 2025, the ratio stands at 50.7%, reflecting working capital of ₩1.05 Trillion against net assets of ₩2.07 Trillion KRW. Check SK Bioscience Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for SK Bioscience Co Ltd (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for SK Bioscience Co Ltd from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SK Bioscience Co Ltd stock valuation.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 62.6% | ₩1.27 Trillion | ₩2.02 Trillion | ₩1.58 Trillion | ₩310.59 Billion | ▼ -10.6 pp |
| 2023 | 73.2% | ₩1.25 Trillion | ₩1.70 Trillion | ₩1.38 Trillion | ₩135.62 Billion | ▼ -7.4 pp |
| 2022 | 80.6% | ₩1.40 Trillion | ₩1.74 Trillion | ₩1.78 Trillion | ₩380.04 Billion | ▼ -5.5 pp |
| 2021 | 86.0% | ₩1.38 Trillion | ₩1.60 Trillion | ₩1.84 Trillion | ₩459.95 Billion | ▲ +27.9 pp |
| 2020 | 58.1% | ₩153.26 Billion | ₩263.79 Billion | ₩333.90 Billion | ₩180.64 Billion | ▲ +4.3 pp |
| 2019 | 53.8% | ₩125.23 Billion | ₩232.73 Billion | ₩170.74 Billion | ₩45.51 Billion | ▼ -2.6 pp |
| 2018 | 56.4% | ₩118.89 Billion | ₩210.73 Billion | ₩180.73 Billion | ₩61.84 Billion | — |